Merger Uncertainty Sends Penny Stock Into Overdrive

Sponsored:

Wednesday, September 17, 2025

Investor sentiment in the biotech and healthcare space often reacts swiftly to corporate transactions. Mergers and acquisitions can reshape a company’s future, but they also come with hurdles, such as financing conditions, regulatory approvals, and shifting market environments. When those timelines change, it can spark sudden volatility in small-cap names.

Shares of SciSparc Ltd. (Nasdaq: SPRC) are skyrocketing Wednesday after AutoMax Motors Ltd. filed a motion with the Jerusalem District Court to delay the companies’ pending merger. The court granted the request, staying proceedings until September 30, 2025, or until notice is filed that the merger’s conditions cannot be satisfied.

The filing stems from AutoMax’s concerns about its ability to meet the closing conditions of the April 2024 merger agreement, following recent business developments. While the request represents a pause rather than a cancellation, it adds a new layer of uncertainty to the transaction’s outcome.

For investors, the postponement means the merger remains on the table, just with a later decision date. Traders seem to be betting heavily on the stock in anticipation of clarity as the new deadline approaches.

Shares of SPRC are currently up 123.9% at $4.11 in late morning trading Wednesday, marking one of the most dramatic moves among U.S.-listed small caps today.

Sponsored: